Omeros | Attività Correnti





Attività Correnti Cambiamento Data
Adma Biologics USD 402.66M 3.1M 2025-09
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Immunic USD 39.27M 20.57M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Knight Therapeutics CAD 397.57M 36.96M 2024-09
MacroGenics USD 232.09M 27.15M 2025-09
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 547.97M 14.78M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09


Omeros Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.